Charles River Laboratories International's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Charles River Laboratories International (CRL)

Q1 2012 Earnings Call

May 03, 2012 8:30 am ET


Susan E. Hardy - Corporate Vice President of Investor Relations

James C. Foster - Chairman, Chief Executive Officer, President and Member of Strategic Planning & Capital Allocation Committee

Thomas F. Ackerman - Chief Financial Officer and Corporate Executive Vice President


David H. Windley - Jefferies & Company, Inc., Research Division

Eric W. Coldwell - Robert W. Baird & Co. Incorporated, Research Division

Gregory T. Bolan - Sterne Agee & Leach Inc., Research Division

Beth Rose

Timothy C. Evans - Wells Fargo Securities, LLC, Research Division

Tycho W. Peterson - JP Morgan Chase & Co, Research Division

Douglas D. Tsao - Barclays Capital, Research Division

John L. Sullivan - Leerink Swann LLC, Research Division

Garen Sarafian - Citigroup Inc, Research Division

Todd Van Fleet - First Analysis Securities Corporation, Research Division

Zachary W. Sopcak - Morgan Stanley, Research Division



Ladies and gentlemen, we'd like to thank you for standing by, and welcome to the Charles River Laboratories' First Quarter 2012 Conference Call. [Operator Instructions] As a reminder, today's conference call will be recorded. I would like to turn the conference over to your hostess and conference facilitator, as well as your Corporate Vice President of Investor Relations, Ms. Susan Hardy. Please go ahead, ma'am.

Susan E. Hardy

Thank you. Good morning, and welcome to Charles River Laboratories' First Quarter 2012 Conference Call and Webcast. This morning, Jim Foster, Chairman, President and Chief Executive Officer; and Tom Ackerman, Executive Vice President and Chief Financial Officer, will comment on our first quarter results and review guidance for 2012. Following the presentation, we will respond to questions.

If you liked this article you might like

Advanced Micro Devices, Micron Technology, Charles River Labs: 'Mad Money' Lightning Round

Profits Trump Economic Weakness: Cramer's 'Mad Money' Recap (Friday 6/2/17)

Parexel Is Discovering the Drugs of the Future

Analysts' Actions -- GE, Nordstrom, Coca-Cola, Eli Lilly and More

Trader's Daily Notebook: For a Decline, It Sure Was Smooth

Trader's Daily Notebook: For a Decline, It Sure Was Smooth